Transactions

Tetracrore Animal Health Products sold to VMRD

Convergence Healthcare advises Tetracore, Inc. in the sale of its animal health product segment to VMRD. Tetracore, Inc., and VMRD, Inc., announced today that Tetracore's animal health products have been purchased by VMRD. A complete list of products is available below. Both organizations are working closely to ensure this transition is smooth and supported for customers. Product descriptions, catalog numbers, and performance characteristics will remain the same. “Our shared priority is the customer experience,” said JJ McCallie, Vice President of Products. “We are committed to delivering …

NIRvana Sciences acquired by Becton Dickinson

NIRvana Sciences, a research-based startup with origins in the lab of professor Jonathan Lindsey, was acquired by the global leading life sciences company in 2025. NIRvana Sciences, a startup company commercializing synthetic red and near-infrared fluorescent dyes for use in diagnostics and imaging, has been acquired by Waters Biosciences, a global leader in life sciences and diagnostics. The startup was acquired by Waters in May 2025 to expand the company’s portfolio of high-performance fluorescent dyes used in flow cytometry and other biomedical applications. NIRvana Sciences — …

Minute Molecular Diagnostics Merges with Nuclein

NEW YORK – Rapid point-of-care qPCR systems developers Nuclein and Minute Molecular Diagnostics announced on Thursday that they have merged. The combined firm, called Nuclein, plans to advance commercialization of a rapid, low-cost qPCR system this summer. Financial terms of the merger were not disclosed. The Nuclein management team will be responsible for daily operations moving forward, while Minute Molecular's former leadership team will continue to support the company. Wally Narajowski, Minute's former chief operating officer, is joining Nuclein's board of directors. The merger …

Sale of Dascena Labs to CirrusDx

CirrusDx Acquires Dascena's Texas Laboratory Business, Expanding Infectious Disease Portfolio ROCKVILLE, Md., Aug. 3, 2022 /PRNewswire/ -- Cirrus Dx, Inc. ("CirrusDx"), an infectious disease diagnostics and laboratory company, announces the acquisition of Dascena Inc.'s Houston-based laboratory business, Dascena Labs, LLC ("Dascena Labs"). Through the acquisition CirrusDx will enhance its current services by further expanding its national laboratory footprint, while strengthening its sequencing capabilities. Dascena Labs is a state-of-the-art CLIA laboratory capable of high-volume …

Sale of Healthmyne to Roche Genentech

…

Sale of Majority Equity Stake in Anodyne to Healthedge Investment Partners

” April 25, 2022 – HealthEdge Investment Partners, LLC (“HealthEdge”), a healthcare focused private equity fund, announced today that it has completed an investment in Anodyne, LLC (“Anodyne”), a leading provider of lifestyle-oriented clinical footwear solutions most commonly prescribed for diabetic patients. Anodyne was founded in 2015 by a group of industry executives who set out to reimagine the diabetic footwear market and establish a new, leading brand—one that would offer patients a variety of modern and stylish shoe selections and suppliers an unmatched service experience. …